FCM
TXG icon

Freshford Capital Management’s 10x Genomics TXG Stock Holding History

Freshford Capital Management’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23M Sell
600,423
-72,533
-11% -$1.9M 7.88% 2
2026
Q1 		$14.3M Sell
672,956
-160,346
-19% -$3.21M 7.14% 4
2025
Q4 		$13.6M Buy
+833,302
New +$12.6M 5.45% 8
2024
Q2 		– Sell
-783,238
Closed -$29.4M – 20
2024
Q1 		$29.4M Buy
783,238
+477,440
+156% +$21M 4.37% 10
2023
Q4 		$17.1M Buy
+305,798
New +$13.3M 2.78% 13

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Freshford Capital Management's TXG Position: Q2 2026 in Review

Freshford Capital Management reduced its 10x Genomics (TXG) stake by 11% in Q2 2026, selling an estimated $1.9M and leaving 600,423 shares worth $23M. The position accounts for 7.88% of the portfolio, ranked #2.

Freshford Capital Management first reported a position in TXG in Q4 2023 and has held it in 5 quarters since. The position peaked at $29.4M in Q1 2024. 392 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Freshford Capital Management held 600,423 shares of 10x Genomics worth $23M as of Q2 2026.
  • Freshford Capital Management sold 72,533 10x Genomics shares in Q2 2026, an estimated $1.9M.
  • 10x Genomics made up 7.88% of Freshford Capital Management's portfolio in Q2 2026, its #2 holding.
  • Freshford Capital Management first reported a position in 10x Genomics in Q4 2023 and has held it in 5 quarters since.
  • Freshford Capital Management's 10x Genomics position peaked at $29.4M in Q1 2024.
  • 392 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Freshford Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.